Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Protectin D1n-3 DPA and resolvin D5n-3 DPA are effectors of intestinal protection.

Gobbetti T, Dalli J, Colas RA, Federici Canova D, Aursnes M, Bonnet D, Alric L, Vergnolle N, Deraison C, Hansen TV, Serhan CN, Perretti M.

Proc Natl Acad Sci U S A. 2017 Apr 11;114(15):3963-3968. doi: 10.1073/pnas.1617290114. Epub 2017 Mar 29.

2.

Alpha-2-macroglobulin loaded microcapsules enhance human leukocyte functions and innate immune response.

Federici Canova D, Pavlov AM, Norling LV, Gobbetti T, Brunelleschi S, Le Fauder P, Cenac N, Sukhorukov GB, Perretti M.

J Control Release. 2015 Nov 10;217:284-92. doi: 10.1016/j.jconrel.2015.09.021. Epub 2015 Sep 16.

3.

Characterization of the anti-inflammatory properties of NCX 429, a dual-acting compound releasing nitric oxide and naproxen.

Amoruso A, Fresu LG, Dalli J, Miglietta D, Bardelli C, Federici Canova D, Perretti M, Brunelleschi S.

Life Sci. 2015 Apr 1;126:28-36. doi: 10.1016/j.lfs.2015.01.025. Epub 2015 Feb 21.

PMID:
25711428
4.

Microparticle alpha-2-macroglobulin enhances pro-resolving responses and promotes survival in sepsis.

Dalli J, Norling LV, Montero-Melendez T, Federici Canova D, Lashin H, Pavlov AM, Sukhorukov GB, Hinds CJ, Perretti M.

EMBO Mol Med. 2014 Jan;6(1):27-42. doi: 10.1002/emmm.201303503. Epub 2013 Dec 15.

5.

Autocrine activation of human monocyte/macrophages by monocyte-derived microparticles and modulation by PPARγ ligands.

Bardelli C, Amoruso A, Federici Canova D, Fresu L, Balbo P, Neri T, Celi A, Brunelleschi S.

Br J Pharmacol. 2012 Feb;165(3):716-28. doi: 10.1111/j.1476-5381.2011.01593.x.

6.

The nitric oxide-donating pravastatin, NCX 6550, inhibits cytokine release and NF-κB activation while enhancing PPARγ expression in human monocyte/macrophages.

Amoruso A, Bardelli C, Fresu LG, Poletti E, Palma A, Federici Canova D, Zeng HW, Ongini E, Brunelleschi S.

Pharmacol Res. 2010 Nov;62(5):391-9. doi: 10.1016/j.phrs.2010.07.006. Epub 2010 Jul 27.

PMID:
20670683

Supplemental Content

Loading ...
Support Center